21Shares 2x Long HYPE ETF

TXXH · ETF

$50.85−$0.5642 (−1.10%)TodayMarket closed ·
Prev close $51.41

About TXXH

TXXH was created on 2026-04-30 by 21Shares. The fund's investment portfolio concentrates primarily on long hype, short usd currency. TXXH provides 2x leveraged exposure to the daily price movement of Hyperliquid (HYPE) through derivatives, net of fees and expenses. The fund will not invest directly in HYPE.

Issuer
21Shares
Expense ratio
1.89%
Assets under management
$4.59M
Inception
Apr 30, 2026
Asset class
Currency

TXXH key statistics

Price-earnings ratio
0.00
Average volume
9.92K
Volume
1.63K
Open price
$51.54
High today
$52.44
Low today
$50.76
52 Week high
$86.40
52 Week low
$23.05

21Shares 2x Long HYPE ETF (TXXH) at a glance

As of Oct 23, 2026, 21Shares 2x Long HYPE ETF (TXXH) shares are priced at $50.85, giving the company a price-to-earnings ratio of 0.00.

Today the fund has traded between $50.76 and $52.44. The current price is 0.2% above the day's low and 3.0% below its high.

Volume so far is 1.63K shares, below the average of 9.92K shares a day.

Over the past year 21Shares 2x Long HYPE ETF has ranged from $23.05 to $86.40, and now sits 44% of the way up that range.

TXXH news

  • Chandrima Sanyal

    EXCLUSIVE: Wall Street Is Betting On A Market Where 'Nothing Happens Off-Chain'

  • Chandrima Sanyal

    Hyperliquid ETF Race Heats Up As Bitwise Launches Staking-Powered BHYP Fund

  • Chandrima Sanyal

    New 2x Leveraged Hyperliquid ETF Brings DeFi Derivatives Exposure To Public Markets

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.